|
" Inotropic Stimulation and Myocardial Energetics "
edited by Hj. Just, Ch. Holubarsch, H. Scholz.
| Document Type
|
:
|
BL
|
| Record Number
|
:
|
731365
|
| Doc. No
|
:
|
b551151
|
| Main Entry
|
:
|
edited by Hj. Just, Ch. Holubarsch, H. Scholz.
|
| Title & Author
|
:
|
Inotropic Stimulation and Myocardial Energetics\ edited by Hj. Just, Ch. Holubarsch, H. Scholz.
|
| Publication Statement
|
:
|
Heidelberg: Steinkopff : Imprint : Steinkopff, 1989
|
| Page. NO
|
:
|
(ix, 273 pages)
|
| ISBN
|
:
|
3662079089
|
|
|
:
|
: 9783662079089
|
| Contents
|
:
|
Introduction: Mechanisms of positive inotropic effects --;Adrenoceptors in myocardial regulation: concomitant contribution from both Alpha- and betaadrenoceptor stimulation to the inotropic response --;Studies on the cellular mechanisms of action of positive and negative inotropic agents --;On the mechanism of positive inotropic effects of alpha-adrenoceptor agonists --;Cytosolic sodium concentration regulates contractility of cardiac muscle --;Energy requirements of contraction and relaxation: implications for inotropic stimulation of the failing heart --;Genetic and non-genetic control of myocardial calcium --;Regulation of force and intracellular calcium transients by cyclic AMP generated by forskolin, MDL 17,043 and isoprenaline, and its modulation by muscarinic receptor agents: a novel mechanism for accentuated antagonism --;Studies on the mechanism of action of the bipyridine milrinone on the heart --;Ca-Agonists: a new class of inotropic drugs --;Myofibrillar Ca++ activation and heart failure --;Ca++ sensitization by the cardiotonic agent APP 201-533 --;Positive inotropic stimulation in the normal and insufficient human myocardium --;Do human cardiac beta-2 adrenoceptors play a (patho)physiological role in regulation of heart rate and/or contractility? --;Influence of isoproterenol on myocardial energetics. Experimental and clinical investigations --;Effects of long-term xamoterol therapy on the left ventricular mechanical efficiency in patients with ischemic heart disease --;Modulation of the autonomic control of the failing heart --;Dopexamine in congestive heart failure: how do the pharmacological activities translate into the clinical situation? --;The use of levodopa, an oral dopamine precursor, in congestive heart failure --;Clinical relevance of long-term therapy with levodopa and orally active dopamine analogues in patients with chronic congestive heart failure --;Cardiovascular effects of forskolin and phosphodiesterase-III inhibitors --;Phosphodiesterase inhibitors: alterations in systemic and coronary hemodynamics --;Influence of the calcium-sensitizer UDCG-115 on hemodynamics and myocardial energetics in patients with idiopathic dilated cardiomyopathy. Comparison with nitroprusside --;Myocardial energetics: experimental and clinical studies to address its determinants and aerobic limit --;Use of a conductance catheter to detect increased left ventricular inotropic state by end-systolic pressure-volume analysis --;Separation between vasodilation and positive inotropism by assessment of myocardial energetics in patients with dilated cardiomyopathy.
|
| Abstract
|
:
|
Inotropic stimulation of the myocardium, as well as vasodilation and diuresis as essential principles in the treatment of congestive heart failure have recently met with considerable criticism and reevaluation.
|
| Subject
|
:
|
Cardiology.
|
| Subject
|
:
|
Human physiology.
|
| Subject
|
:
|
Medicine.
|
| LC Classification
|
:
|
RM349.E358 1989
|
| Added Entry
|
:
|
Ch Holubarsch
|
|
|
:
|
H Scholz
|
|
|
:
|
Hj Just
|
| |